Heba El-Mansi

Prof. Heba El-Mansi

Pharmaceutical Analytical Chemistry, Mansoura University, Al Manşūrah, Ad Daqahlīyah, Egypt

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Microchemical Journal
Verified
Journal Article
Closed access
IMIbraam E. Mikhail
Ibraam E. Mikhail
HEHeba El-Mansi
Heba El-Mansi
FBFathalla Belal
Fathalla Belal
AIAdel Ehab Ibrahim
Adel Ehab Ibrahim

1 February 2023 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
GMGalal Magdy
Galal Magdy
HEHeba El-Mansi
Heba El-Mansi
FBFathalla Belal
Fathalla Belal
AEAsmaa Kamal El-Deen
Asmaa Kamal El-Deen
Carbon dots (CDs) have recently attracted attention as a new class of photoluminescent materials with promising optical, chemical, and electrical properties. They have been proposed for various applications, such as pharmaceutical sensing, biomarker detection, and cellular bioimaging, by virtue of their economical synthesis, cheap starting materials, water-solubility, excellent chemical stability, good biocompatibility, and low toxicity. Hetero-atom doping is a reliable and adaptable strategy for enhancing the photoluminescence, electrical, and structural characteristics of CDs. Herein, we present an update on heteroatom-doped CDs. Various modern synthetic routes are highlighted, ranging from synthetic processes to doping components. In addition, the optical and biological properties and the possible applications of heteroatom-doped CDs are discussed. This review will provide an overview of recent advances in doped CDs and their expected future perspectives.

31 January 2023 in RSC Advances
Verified
Journal Article
Open access
PDF file
GMGalal Magdy
Galal Magdy
FBFathalla Belal
Fathalla Belal
HEHeba El-Mansi
Heba El-Mansi
The current study introduces a spectrofluorimetric methodology for the assessment of palbociclib without the need for any pre-derivatization steps for the first time. This approach relied on the palbociclib quenching effect on the native fluorescence of newly synthesized nitrogen-doped carbon quantum dots (N-CQDs). An innovative, facile, and rapid microwave-assisted pyrolysis procedure was applied for the synthesis of N-CQDs using available and economic starting materials (the carbon source is orange juice and the nitrogen source is urea) in less than 10 minutes. Full characterization of the prepared QDs was carried out using various techniques. The prepared N-CQDs exhibited good fluorescence emission at 417 nm after excitation at 325 nm with stable fluorescence intensity and good quantum yield (29.3%). They showed spherical shapes and narrow size distribution with a particle size of around 2–5 nm. Different experimental variables influencing fluorescence quenching were examined and optimized. A good linear correlation was exhibited alongside the range of 1.0 to 20.0 μg mL−1 with a correlation coefficient of 0.9997 and a detection limit of 0.021 μg mL−1. The proposed methodology showed good selectivity allowing its efficient application in tablets with high percentage recoveries and low percentage RSD values. The mechanism of quenching was proved to be static by applying the Stern–Volmer equation at four different temperatures. The method was validated in accordance with ICHQ2 (R1) recommendations. Intriguingly, N-CQDs demonstrated good biocompatibility and low cytotoxicity, which permitted cellular imaging and palbociclib detection in living cancer cells. Therefore, the proposed method may have potential applications in cancer therapy and related mechanism research.


3 March 2023 in Molecules
Verified
Journal Article
Open access
PDF file
MAManal A. Alossaimi
Manal A. Alossaimi
HEHeba El-Mansi
Heba El-Mansi
MAMai Alajaji
Mai Alajaji
AAAli Altharawi
Ali Altharawi
AAAbdulmalik S. A. Altamimi
Abdulmalik S. A. Altamimi
GMGalal Magdy
Galal Magdy
One of the most promising drugs recently approved for the treatment of various types of cancer is dacomitinib, which belongs to the tyrosine kinase inhibitor class. The US Food and Drugs Administration (FDA) has recently approved dacomitinib as a first-line treatment for patients suffering from non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations. The current study proposes the design of a novel spectrofluorimetric method for determining dacomitinib based on newly synthesized nitrogen-doped carbon quantum dots (N-CQDs) as fluorescent probes. The proposed method is simple and does not require pretreatment or preliminary procedures. Since the studied drug does not have any fluorescent properties, the importance of the current study is magnified. When excited at 325 nm, N-CQDs exhibited native fluorescence at 417 nm, which was quantitatively and selectively quenched by the increasing concentrations of dacomitinib. The developed method involved the simple and green microwave-assisted synthesis of N-CQDs, using orange juice as a carbon source and urea as a nitrogen source. The characterization of the prepared quantum dots was performed using different spectroscopic and microscopic techniques. The synthesized dots had consistently spherical shapes and a narrow size distribution and demonstrated optimal characteristics, including a high stability and a high fluorescence quantum yield (25.3%). When assessing the effectiveness of the proposed method, several optimization factors were considered. The experiments demonstrated highly linear quenching behavior across the concentration range of 1.0−20.0 μg/mL with a correlation coefficient (r) of 0.999. The recovery percentages were found to be in the range of 98.50–100.83% and the corresponding relative standard deviation (%RSD) was 0.984. The proposed method was shown to be highly sensitive with a limit of detection (LOD) as low as 0.11 μg/mL. The type of mechanism by which quenching took place was also investigated by different means and was found to be static with a complementary inner filter effect. For quality purposes, the assessment of the validation criteria adhered to the ICHQ2(R1) recommendations. Finally, the proposed method was applied to a pharmaceutical dosage form of the drug (Vizimpro® Tablets) and the obtained results were satisfactory. Considering the eco-friendly aspect of the suggested methodology, using natural materials to synthesize N-CQDs and water as a diluting solvent added to its greenness profile.

26 May 2023 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
MAManal A. Alossaimi
Manal A. Alossaimi
AAAbdulmalik S.A. Altamimi
Abdulmalik S.A. Altamimi
HEHeba El-Mansi
Heba El-Mansi
GMGalal Magdy
Galal Magdy